Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered

Journal of Hepatology

Volumn 51, Issue 2, 2009, Pages 389-397

  McPherson, Stuart ^a,b,d   Jonsson, Julie R ^b   Cowin, Gary J ^b   O'Rourke, Peter ^c   Clouston, Andrew D ^b   Volp, Andrew ^a   Horsfall, Leigh ^a   Jothimani, Dinesh ^a,b   Fawcett, Jonathan ^a,b   Galloway, Graham J ^b   Benson, Mark ^a   Powell, Elizabeth E ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Fibrosis; Magnetic resonance imaging; Steatosis

Indexed keywords

TRIACYLGLYCEROL;

ARTICLE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FATTY LIVER; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPID LIVER LEVEL; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

BIOPSY, NEEDLE; CELL COUNT; COHORT STUDIES; FATTY LIVER; FEMALE; HEPATOCYTES; HUMANS; IRON; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; TRIGLYCERIDES;

EID: 67649205135     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.04.012     Document Type: Article

References (28)

1. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395
2. Chalasani N., Wilson L., Kleiner D.E., Cummings O.W., Brunt E.M., and Unalp A. Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J Hepatol 48 (2008) 829-834
3. Bugianesi E., Marchesini G., Gentilcore E., Cua I.H.Y., Vanni E., Rizzetto M., et al. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis. Hepatology 44 (2006) 1648-1655
4. Powell E.E., Jonsson J.R., and Clouston A.D. Steatosis: co-factor in other liver diseases. Hepatology 42 (2005) 5-13
5. Powell E.E., Ali A., Clouston A.D., Dixon J.L., Lincoln D.J., Purdie D.M., et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 129 (2005) 1937-1943
6. Kooby D.A., Fong Y., Suriawinata A., Gonen M., Allen P.J., Klimstra D.S., et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7 (2003) 1034-1044
7. Mehta S.R., Thomas E.L., Bell J.D., Johnston D.G., and Taylor-Robinson S.D. Non-invasive means of measuring hepatic fat content. World J Gastroenterol 14 (2008) 3476-3483
8. Cowin G.J., Jonsson J.R., Bauer J.D., Ash S., Ali A., Osland E.J., et al. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 28 (2008) 937-945
9. Longo R., Pollesello P., Ricci C., Masutti F., Kvam B.J., Bercich L., et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5 (1995) 281-285
10. Longo R., Ricci C., Masutti F., Vidimari R., Croce L.S., Bercich L., et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 28 (1993) 297-302
11. Thomsen C., Becker U., Winkler K., Christoffersen P., Jensen M., and Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12 (1994) 487-495
12. Mazhar S.M., Shiehmorteza M., and Sirlin C.B. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 7 (2009) 135-140
13. Dixon W.T. Simple proton spectroscopic imaging. Radiology 153 (1984) 189-194
14. Fishbein M., Castro F., Cheruku S., Jain S., Webb B., Gleason T., et al. Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 39 (2005) 619-625
15. Qayyum A., Goh J.S., Kakar S., Yeh B.M., Merriman R.B., and Coakley F.V. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques - initial experience. Radiology 237 (2005) 507-511
16. Bedossa P., and Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24 (1996) 289-293
17. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
18. Bedossa P., Bioulacsage P., Callard P., Chevallier M., Degott C., Deugnier Y., et al. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 20 (1994) 15-20
19. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
20. Saadeh S., Younossi Z.M., Remer E.M., Gramlich T., Ong J.P., Hurley M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 745-750
21. Charatcharoenwitthaya P., and Lindor K.D. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis 11 (2007) 37-54
22. Rinella M.E., McCarthy R., Thakrar K., Finn J.P., Rao S.M., Koffron A.J., et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl 9 (2003) 851-856
23. Pilleul F., Chave G., Dumortier J., Scoazec J.Y., and Valette P.J. Fatty infiltration of the liver - detection and grading using dual T1 gradient echo sequences on clinical MR system. Gastroenterol Clin Biol 29 (2005) 1143-1147
24. Westphalen A.C.A., Qayyum A., Yeh B.M., Merriman R.B., Lee J.A., Lamba A., et al. Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 242 (2007) 450-455
25. Bahl M., Qayyum A., Westphalen A.C., Noworolski S.M., Chu P.W., Ferrell L., et al. Liver steatosis: Investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers. Radiology 249 (2008) 160-166
26. Bosch J. Towards the non-invasive diagnosis of cirrhosis: the nuts-cirrhosis connection. J Hepatol 50 (2009) 4-6
27. Castera L. Non-invasive diagnosis of steatosis and fibrosis. Diabetes Metab 34 (2008) 674-679
28. Pinzani M., Vizzutti F., Arena U., and Marra F. Technology insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Nat Clin Pract Gastroenterol Hepatol 5 (2008) 95-106